Wang Rong-fu, Liu Meng
Department of Nuclear Medicine, Peking University First Hospital, Beijing 100034, China.
Beijing Da Xue Xue Bao Yi Xue Ban. 2007 Oct 18;39(5):550-4.
Neuroreceptor imaging with radionuclide tracing in vivo has been greatly developed recently. Distribution, density, and activity of receptors in the brain can be visualized by the radioligands labeled for emission computed tomography (ECT), including PET (positron emission tomography) and SPECT (single photon emission computed tomography). The functional and quantitative imaging for several receptors, such as dopamine receptors, serotonin receptors, cholinergic receptors, benzodiazepine receptors, and opioid receptors, has clinical importance. The preparation of receptor imaging agents, foundation of the physio-mathematical model, and the development of nuclear medicine instruments are the main points. In the present review, we will concentrate on introducing the development of brain receptor imaging.
近年来,体内放射性核素示踪神经受体成像技术得到了极大的发展。通过标记用于发射计算机断层扫描(ECT)的放射性配体,可以可视化大脑中受体的分布、密度和活性,包括正电子发射断层扫描(PET)和单光子发射计算机断层扫描(SPECT)。对几种受体,如多巴胺受体、5-羟色胺受体、胆碱能受体、苯二氮䓬受体和阿片受体进行功能和定量成像具有临床意义。受体显像剂的制备、生理数学模型的建立以及核医学仪器的发展是主要要点。在本综述中,我们将集中介绍脑受体成像的发展。